GLP-compliant Confirmatory Sequencing
GENEWIZ’s Confirmatory Sequencing under Good Laboratory Practice (GLP) guidelines provides confirmation of the biologic using Sanger sequencing to support FDA- and EPA- submissions.
GENEWIZ’s Confirmatory Sequencing under Good Laboratory Practice (GLP) guidelines provides confirmation of the biologic using Sanger sequencing to support FDA- and EPA- submissions.
Good Laboratory Practice (GLP) services from GENEWIZ are designed to be compliant with US FDA (21 CFR Part 58) and US EPA (40 CFR Part 160) regulations to support pre-marketing authorizations.
Clinical Genome Sequencing provides a CLIA-validated comprehensive analysis of the entire genome to uncover mutations in coding and non-coding regions, including structural and copy number variants.
Clinical Exome Sequencing is a CLIA-validated method to probe protein-coding regions of the genome at high depth and with uniform coverage. Our regulatory service provides whole exome sequencing services in our GCP-compliant, CAP-accredited laboratory.
GENEWIZ provides CLIA Sanger sequencing as the clinical "gold standard" from our state-of-the-art CLIA-certified and CAP-accredited laboratory.
CLIA variant confirmation via PCR + Sanger sequencing is used to detect or confirm mutations within genomic DNA.
To support pre-clinical and clinical regulatory submissions, GENEWIZ has established Good Laboratory Practices (GLP) and Clinical Laboratory Improvement Amendments (CLIA)-compliant workflows.
GENEWIZ AAV Plasmid Preparation service delivers superior quality for midi to giga-scale AAV vectors, while maintaining the integrity of ITR regions.
GENEWIZ Targeted Yield Plasmid DNA Preparation Service delivers specific quantities of high quality, transfection-grade DNA that you can count on.
GENEWIZ Standard Plasmid DNA Preparation Service is a flexible and fast choice for a range of plasmid templates.